CORRECTION article

Front. Pharmacol., 04 January 2023

Sec. Respiratory Pharmacology

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1036927

Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

  • 1. State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

  • 2. Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao, China

  • 3. The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

  • 4. Guangzhou Laboratory, Guangdong, China

  • 5. State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, China

Article metrics

View details

5

Citations

1,4k

Views

652

Downloads

In the published article, an error was made in the Title, “Investigating the effects of Liushen Capsules on the metabolome of seasonal influenza: A randomized clinical trial,” instead of “Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial.”

In the published article, there was an error in the Author list, and author “Jing Zeng, Qihua Wu and Bojun Chen” were erroneously excluded. The equal contributions of QM, RC, and JZ were also not signposted in the author list. The corrected author list appears below.

“Qinhai Ma1†, Ruihan Chen1,2†, Jing Zeng3†, Biao Lei1, Feng Ye1*, Qihua Wu3, Zhengtu Li1, Yangqing Zhan1, Bin Liu1, Bojun Chen3* and Zifeng Yang1,4,5*.”

In the published article, the following affiliation was not included “The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.”

In the published article, there was an error in Table 7 (Adverse events in LS and Placebo group during trial).

TABLE 7

EventLS (N = 46)Placebo (N = 44)
Any adverse event32 (71.11)26 (59.09)
Vomiting17 (53.13)2 (7.69)
Nausea16 (50.00)5 (19.23)
Cough and sputum11 (34.38)13 (50.00)
Diarrhea7 (21.88)7 (26.92)
Stomach discomfort3 (9.38)2 (7.69)
Nasal congestion1 (3.13)
Gastrointestinal discomfort1 (3.13)1 (3.85)
Pneumonia1 (3.13)1 (3.85)
Abdominal rash1 (3.13)
bloating1 (3.13)1 (3.85)
Mouth ulcers1 (3.13)
Urine occult blood 3+1 (3.13)
Fatigue1 (3.13)1 (3.85)
Subconjunctival hemorrhage1 (3.13)
Upper respiratory tract infection1 (3.13)1 (3.85)
Dizziness1 (3.13)
Bacterial Infections1 (3.13)
Sore Throat1 (3.13)1 (3.85)
Foreign body sensation in the left eye1 (3.13)
Decrease in white blood cells1 (3.85)
Urinary Infections1 (3.85)
Elevated urine leukocytes1 (3.85)
Stabbing pain in the chest1 (3.85)

Adverse events in LS and Placebo group during trial.

The corrected Table 7 and its caption appear below.

A correction has been made to Author contributions, Paragraph Number 1503–1509. This statement previously stated:

“QM, ZY conceived and designed the study; QM, RC performed the study and analyzed the data; QM, RC, BLe wrote the paper; ZY, FY, ZL, YZ, BLi supervised the study and revised the manuscript. All authors read and approved the final manuscript.”

The corrected statement appears below:

“QM and ZY conceived and designed the study; BC, QM, RC, JZ, and QW performed the study, collected the clinical samples and analyzed the data; QM, RC, JZ, and BLe wrote the paper; ZY, BC, FY, ZL, YZ, and BLi supervised the study and revised the manuscript. All authors read and approved the final manuscript.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

influenza virus, liushen capsules, clinical trial, non-targeted metabolomics, Chinese traditional medicines

Citation

Ma Q, Chen R, Zeng J, Lei B, Ye F, Wu Q, Li Z, Zhan Y, Liu B, Chen B and Yang Z (2023) Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial. Front. Pharmacol. 13:1036927. doi: 10.3389/fphar.2022.1036927

Received

05 September 2022

Accepted

13 December 2022

Published

04 January 2023

Volume

13 - 2022

Edited by

Chia-Jung Li, Kaohsiung Veterans General Hospital, Taiwan

Reviewed by

Jianguo Li, Shanxi University, China

Updates

Copyright

*Correspondence: Feng Ye, ; Bojun Chen, ; Zifeng Yang,

†These authors have contributed equally to this work

This article was submitted to Respiratory Pharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics